Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length

Biochemical and Biophysical Research Communications

Volumn 316, Issue 4, 2004, Pages 1116-1123

  Song, Hai ^a   Li, Yiliang ^a   Chen, Guoyuan ^a   Xing, Zhen ^a   Zhao, Jing ^a   Yokoyama, Kazunari K ^b   Li, Tsaiping ^a   Zhao, Mujun ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

cDNA; Cell cycle regulation; Nucleolar protein; Telomerase inhibitor; Yeast two hybrid screening

Indexed keywords

CELL CYCLE PROTEIN; MICROSPHERULE PROTEIN 1; NUCLEAR PROTEIN; PROTEIN LPTS; TELOMERASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE S PHASE; CELL LINE; CELLULAR DISTRIBUTION; ENZYME INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TELOMERE;

BASE SEQUENCE; BRAIN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEINS; RNA-BINDING PROTEINS; TELOMERE; TUMOR SUPPRESSOR PROTEINS;

EID: 1642338831     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.166     Document Type: Article

References (33)

1. Blackburn E.H. Switching and signaling at the telomere. Cell. 106:2001;661-673.
2. de Lange T. Protection of mammalian telomeres. Oncogene. 21:2002;532-540.
3. Kim S.H., Kaminker P., Campisi J. Telomeres, aging and cancer: in search of a happy ending. Oncogene. 21:2002;503-511.
4. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science. 297:2002;565-569.
5. Nugent C.I., Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:1998;1073-1085.
6. van Steensel B., de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 385:1997;740-743.
7. Smogorzewska A., van Steensel B., Bianchi A., Oelmann S., Schaefer M.R., Schnapp G., de Lange T. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 20:2000;1659-1668.
8. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly (ADP-ribose) polymerase at human telomeres. Science. 282:1998;1484-1487.
9. Kim S.H., Kaminker P., Campisi J. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23:1999;405-412.
10. Zhou X.Z., Lu K.P. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell. 107:2001;347-359.
11. Li B., Oestreich S., de Lange T. Identification of human Rap1: implications for telomere evolution. Cell. 101:2000;471-483.
12. Loayza D., de Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature. 423:2003;1013-1018.
13. Colgin L.M., Baran K., Baumann P., Cech T.R., Reddel R.R. Human POT1 facilitates telomere elongation by telomerase. Curr. Biol. 13:2003;942-946.
14. Liao C., Zhao M.J., Song H., Uchida K., Yokoyama K.K., Li T.P. Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology. 32:2000;721-727.
15. Liao C., Zhao M.J., Zhao J., Jia D., Song H., Li Z.P. Over-expression of LPTS-L in hepatocellular carcinoma cell line SMMC-7721 induces crisis. World J. Gastroenterol. 8:2002;1050-1052.
16. Park W.S., Lee J.H., Park J.Y., Jeong S.W., Shin M.S., Kim H.S., Lee S.K., Lee S.N., Lee S.H., Park C.G., Yoo N.J., Lee J.Y. Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas. Cancer Lett. 178:2002;199-207.
17. Bruni R., Roizman B. Herpes simplex virus 1 regulatory protein ICP22 interacts with a new cell cycle-regulated factor and accumulates in a cell cycle-dependent fashion in infected cells. J. Virol. 72:1998;8525-8531.
18. Ren Y., Busch R.K., Perlaky L., Busch H. The 58-kDa microspherule protein (MSP58), a nucleolar protein, interacts with nucleolar protein p120. Eur. J. Biochem. 253:1998;734-742.
19. Lin D.Y., Shih H.M. Essential role of the 58-kDa microspherule protein in the modulation of daxx-dependent transcriptional repression as revealed by nucleolar sequestration. J. Biol. Chem. 277:2002;25446-25456.
20. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature. 345:1990;458-460.
21. Kim N.W., Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25:1997;2595-2597.
22. Fangman W.L., Brewer B.J. A question of time: replication origins of eukaryotic chromosomes. Cell. 71:1992;363-366.
23. Sandell L.L., Zakian V.A. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell. 75:1993;729-739.
24. Taggart A.K., Teng S.C., Zakian V.A. Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science. 297:2002;1023-1026.
25. Holt S.E., Wright W.E., Shay J.W. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16:1996;2932-2939.
26. Wright W.E., Tesmer V.M., Liao M.L., Shay J.W. Normal human telomeres are not late replicating. Exp. Cell Res. 251:1999;492-499.
27. Wong J.M., Kusdra L., Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 4:2002;731-736.
28. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., Hahn W.C. Telomerase maintains telomere structure in normal human cells. Cell. 114:2003;241-253.
29. Zhou X.Z., Perrem K., Lu K.P. Role of Pin2/TRF1 in telomere maintenance and cell cycle control. J. Cell Biochem. 89:2003;19-37.
30. Bader A.G., Schneider M.L., Bister K., Hartl M. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1). Oncogene. 20:2001;7524-7535.
31. Hofmann K., Bucher P. The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. Trends Biochem. Sci. 20:1995;347-349.
32. Durocher D., Henckel J., Fersht A.R., Jackson S.P. The FHA domain is a modular phosphopeptide recognition motif. Mol. Cell. 4:1999;387-394.
33. Li J., Lee G.I., Van Doren S.R., Walker J.C. The FHA domain mediates phosphoprotein interactions. J. Cell Sci. 113:2000;4143-4149.